Diagnostic Usefulness of Cell Block Samples in Fluid Overload-Associated Large B-Cell Lymphoma.

Diagn CytopatholAug 11, 2026 (epub)

Hiroyuki Okanishi, Hiroko Kuwabara, Hiroko Nakayama et al.

✦ AI-curated · Sources linked

Case in brief

An 81-year-old woman presented with pericardial and pleural effusions and was diagnosed with stage IVA fluid overload-associated large B-cell lymphoma (FO-LBCL), despite having no underlying condition that could explain fluid overload. Cytology from both effusions showed atypical medium- to large-sized lymphoid cells. Immunohistochemistry on the pleural-fluid cell block showed CD20 and CD79a positivity, with negative CD3, KSHV/HHV-8, and Epstein-Barr virus; the Ki-67 labeling index was 95%. After systemic chemotherapy, she achieved complete remission, with no pleural or pericardial recurrence during 3-year follow-up.

What made this case unusual

The patient had FO-LBCL with serous effusions despite no underlying medical condition that could lead to fluid overload.

Diagnostic / clinical pearl

In suspected FO-LBCL, cell-block immunohistochemistry can help confirm the diagnosis from effusion cytology and inform therapy selection, alongside clinical and imaging findings.

Source

Published in Diagn Cytopathol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pathology (Anatomic & Clinical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.